News at Columbia SPS Category - Any -AlumniFacultyImpacts and InsightsIn the CommunityIn the MediaKnowledge BaseOffice of the DeanPress ReleaseResearch & PublicationsSchoolStaffStudent Faculty Instructor Simon Sinek Featured by 99% Simon Sinek, an instructor in the M.S. in Strategic Communications program, gave a presentation on leadership for The 99%. School The Ten Best Jobs of 2012 According to The Wall Street Journal and CareerCast's "Top Jobs of 2012", actuaries have the second-best job in the country. Faculty Are We Our Genes? Ethics and religion writer Bill Tammeus has published a review of Robert Klitzman's book Am I My Genes? School Have You Missed An Event With Our Bioethics Program Lately? The Bioethics program recently hosted a number of events. Faculty Sharing Office Cubicles... And Diagnoses Dr. Robert Klitzman writes on the pros and cons of sharing health diagnoses and problems with the office. Faculty Don’t Mind Us Snooping Through Your Genes Dr. Robert Klitzman discusses the ethical challenges brought about by the digitalization of medical information and history. Faculty Genes and Autism: The Good, the Bad, and the Ugly Dr. Klitzman writes about the intersection of ethics, genome mapping and the discovery of the “autism gene.” Faculty Am I My Genes: Why Do I Have These Genes? Questions of Fate, Free Will, and Genetics Dr. Klitzman will be blogging for Psychology Today on the subject of his recently released book, Am I My Genes? Faculty UPDATED: Dr. Robert Klitzman's newest book, "Am I My Genes?" positively reviewed In his new book, "Am I My Genes," Dr. Robert Klitzman addresses the timely issues surrounding genetic testing. Faculty Bioethics Program Director Robert Klitzman on the NPR program Talk of the Nation On NPR, Dr. Robert Klitzman discusses his book "Am I My Genes? Faculty When Scientists Lie “We tend to trust scientists,” says Robert Klitzman, M.D. in Men's Health. “As a result, a few bad apples can be faking things. Faculty World AIDS Day 2011: Entering The Fourth Decade Of HIV Dr. Klitzman writes about the promises of new HIV drugs, and economic problems of drug access. Load More
